As of late 2025, Zurich hosts between 876 and 1,794 startups depending on which database you check[1][2][3]. Lausanne supports around 188 startups[4]. But raw numbers tell only part of the story. Lausanne creates nearly the same number of new startups as Zurich despite having only one-third of the population[5]. This statistic suggests very high entrepreneurial density. The funding gap is large: Zurich-based startups raised CHF 872 million in 2023[6][7]. All startups in the canton of Vaud (which includes Lausanne) raised CHF 548.6 million in 2022[8].
For founders, the ecosystem choice shapes access to capital, talent costs, corporate partnerships, and market positioning. For investors, understanding regional dynamics helps identify sector-specific deal flow. It also helps evaluate founder location decisions. Family offices with cantonal preferences can build better portfolios by knowing which regions excel in which sectors.
This analysis looks at seven key areas: funding landscape, academic infrastructure, investor networks, corporate partnerships, talent dynamics, support programs, and market access. We also cover Basel’s biotech strength and Zug’s Crypto Valley. These specialized hubs complement rather than compete with Zurich and Lausanne.
Sector Specialization: Following the Research Strengths
The clearest difference between Zurich and Lausanne lies in sector focus. This flows directly from what their universities research.
Zurich dominates in:
- Fintech and financial services software
- Artificial Intelligence and machine learning (10 of 37 ETH spin-offs in 2024)[9]
- Robotics and automation
- Deep tech requiring large engineering teams
- B2B software serving enterprise clients
Lausanne excels in:
- Life sciences and biotechnology
- Medical devices and healthcare technology
- Cleantech and sustainability solutions
- Robotics with a hardware focus
- Food technology and agricultural innovation
These patterns show up in the numbers. In 2022, startups in Vaud captured 66.8% of all Swiss medtech investment capital[10]. Basel separately captured 44% of Swiss biotech venture capital in 2024. That equals CHF 328 million[11]. Basel is the clear leader in pharma and therapeutics. Zurich attracted 34% of total Swiss venture capital across all sectors in 2023[12], showing the city’s overall importance in Swiss innovation.
For investors, specialization creates predictable deal flows. A family office seeking exposure to AI should focus on Zurich’s ETH AI Center ecosystem. An investor committed to climate technology will find Lausanne’s EPFL cleantech pipeline more relevant. In 2024, 17% of EPFL startups focused on sustainability[13].
For founders, sector fit matters more than general ecosystem rankings. A fintech seeking partnerships with UBS or Credit Suisse should operate in Zurich. A medtech requiring wet lab space and hospital partnerships should take advantage of Lausanne’s Biopôle campus. Biopôle hosts specialized life sciences facilities and sits close to university hospitals.
Academic Infrastructure: ETH vs. EPFL
Both cities benefit from world-class technical universities. But their spin-off models work differently.
ETH Zurich produced 43 spin-offs in 2023 and 37 in 2024[14][15]. This shows consistent output at scale. These spin-offs raised CHF 425 million across 42 funding rounds in 2024 alone[16]. The university’s strength in computer science and engineering translates directly into AI and robotics ventures. Notable 2024 spin-offs include mimic (humanoid robotics, $16 million seed round)[17] and YQuantum (quantum computing hardware, CHF 150’000 from Venture Kick)[18].
ETH’s ecosystem emphasizes commercial viability early. The ETH Pioneer Fellowship program and the ETH Student Project House provide clear paths from research to incorporation[19]. The university reports that 93% of ETH spin-offs survive their first five years. Also, 95% remain in Switzerland[20], showing strong ecosystem integration.
EPFL operates a different model centered on the EPFL Innovation Park. The park houses 2,837 entrepreneurs and staff across more than 150 startups and 25 corporate R&D centers[21][22]. Rather than pure spin-off volume, EPFL focuses on deep research commercialization in life sciences and sustainability. The university’s Ignition Grant provides CHF 30’000 to early-stage projects. Four startups received this funding in 2024[23].
EPFL’s ecosystem produces fewer but often more capital-intense ventures. Recent examples include Neural Concept (AI design platform, $27 million raised in 2024)[24] and DPhi Space (satellite platform, €2.4 million in 2024)[25]. The nearby Biopôle life sciences campus creates unique infrastructure for medtech and biotech. ETH cannot replicate this in Zurich.
For founders, the university connection matters beyond facilities. ETH provides access to Germany’s largest technical university network. It also offers a talent pool rated second globally in computer science[26]. EPFL draws from over 120 nationalities[27]. It provides natural paths to French-speaking markets and Geneva’s international organizations.
For investors evaluating academic spin-offs, due diligence should account for these structural differences. ETH spin-offs often enter markets with clearer go-to-market strategies. EPFL spin-offs may require longer development timelines but address problems with higher technical barriers to entry.
Funding Landscape: Volume vs. Specialization
The funding difference between Zurich and Lausanne is large but getting smaller.
Zurich hosts 168 private equity and venture capital firms across the greater financial region, which includes Zug and Schwyz. 63% of the firms are in the canton of Zurich itself[28]. Major firms include Redalpine (€179 million fund closed in August 2024)[29], Founderful ($85 million fund raised in 2024)[30], and btov Partners. These firms provide both early-stage and growth capital across multiple sectors.
The concentration of financial services creates natural paths for fintech startups. Zurich Insurance Group’s Innovation Championship has led to over 50 ongoing collaborations with startups. Winners receive up to $100’000 in project funding[31]. UBS and ETH Zurich held a joint investor event in March 2024. It connected 50 spin-offs with over 200 investors[32].
Lausanne operates with a smaller but highly specialized investor base. The canton of Vaud created Initiative Capital Romandie with CHF 15.5 million. The fund specifically targets early-stage IT and life sciences companies in the region[33]. Swisscom Ventures and Debiopharm Innovation Fund are active regional investors[34]. The EPFL Investor Day attracted over 900 attendees in 2024[35]. This shows strong ecosystem engagement despite lower overall capital volume.
International venture capital reaches both ecosystems but through different channels. Zurich startups recently secured funding from Silicon Valley’s Felicis ($41.2 million Series A)[36] and European firms Elaia and Speedinvest (mimic’s $16 million round)[37]. Lausanne’s HAYA Therapeutics secured a partnership with pharmaceutical giant Lilly. The deal is worth up to $1 billion[38]. These deals show that specialized life sciences ventures can attract global capital despite the smaller local VC presence.
For founders raising seed rounds, Zurich offers higher probability of finding local capital. For founders in specialized verticals like medtech or cleantech, Lausanne’s focused investor base may provide better sector expertise. They may offer more relevant network connections despite smaller check sizes.
For family offices and institutional investors, Zurich provides diversified deal flow across sectors. Lausanne offers concentrated exposure to high-barrier deep tech and life sciences.
Talent and Cost Dynamics: The Price of Excellence
Both cities provide world-class technical talent. But pay and living costs differ meaningfully.
Software engineer salaries in Zurich average around CHF 125’000 per year as of late 2025[39]. Senior engineers earn CHF 140’000 to CHF 155’000. Lausanne salaries for comparable roles range from CHF 105’000 to CHF 117’000[40]. The gap narrows for highly specialized roles in AI and machine learning. EPFL-trained talent commands premium pay in these areas.
The cost of living difference partly offsets salary differences. Zurich’s cost of living stands 27% above the Swiss national average[41]. Lausanne sits at 7% above the average[42]. Office and lab space costs follow similar patterns. But specific data for startup facilities remains limited.
For founders managing burn rate, the CHF 10’000 to CHF 20’000 annual salary difference per engineer adds up quickly. Across a 10-person technical team, there could be CHF 100’000 to CHF 200’000 in annual savings by locating in Lausanne. But this calculation must account for the larger talent pool in Zurich. A bigger pool may reduce hiring timelines and competition for specialized skills.
Both ecosystems operate primarily in English within the startup and tech sectors. French language ability provides advantages in Lausanne for engaging with cantonal government support programs and local corporate partnerships.
For investors evaluating founder decisions, cost optimization without hurting talent quality suggests operational sophistication. A Lausanne-based AI startup paying near-Zurich salaries to EPFL graduates may signal a strong value proposition to employees. A Zurich-based startup offering below-market pay may face talent retention challenges.
Corporate Partnership Opportunities: Finance vs. Pharma
Corporate engagement with startups follows predictable patterns based on industry concentration.
Zurich provides direct access to Switzerland’s financial services headquarters. UBS, Credit Suisse (now integrated with UBS), Swiss Re, and Zurich Insurance Group all maintain innovation programs and corporate venture arms. Google’s Zurich office employs around 5’000 people in the company’s largest engineering center outside the United States[43].
These corporations actively partner with startups through structured programs. Beyond Zurich Insurance’s Innovation Championship, UBS has launched partnerships with startups like Numarics. It also hosts the Deep Tech Nation foundation jointly with Swisscom. The City of Zurich introduced KlimUp funding in 2024. The program provides CHF 35’000 to CHF 250’000 for climate startups. Nine companies received funding in the first year[44].
Lausanne’s corporate landscape centers on Nestlé. The company operates its R&D Accelerator as a six-month intensive program for food and beverage startups[45]. Logitech maintains a major presence at EPFL Innovation Park. The proximity to Geneva (62 kilometers) provides access to international organizations and Geneva’s medtech cluster.
Basel operates as a specialized corporate hub for biotech partnerships. Roche and Novartis serve as partners for the BaseLaunch incubator. BaseLaunch provides up to CHF 500’000 per startup[46][47]. Recent acquisitions show active corporate development. AstraZeneca acquired Basel-based SixPeaks Bio in 2024[48]. Roche acquired T3 Pharma for CHF 450 million in 2023[49].
For founders, corporate partnerships serve multiple functions beyond capital. Pilot programs provide product validation, which is particularly valuable for B2B software and enterprise solutions. Corporate venture arms offer patient capital with strategic alignment. Acquisition exits by corporations represent many Swiss startup exits.
For investors, corporate engagement signals suggest market validation and potential exit paths. A Zurich fintech in UBS’s innovation program has likely navigated initial customer development challenges. A Lausanne medtech with a Nestlé partnership has likely validated product-market fit with a sophisticated corporate buyer.
Accelerator and Support Programs: Zero-Equity vs. University-Embedded
Both ecosystems provide extensive support. But program structures differ.
Zurich hosts multiple accelerators targeting different stages and sectors:
- Bluelion operates a leading tech incubator with an active acceleration program[50]
- Tenity (formerly F10) focuses on fintech and insurtech, offering CHF 50’000 for a 2.5% equity stake[51]
- Kickstart Innovation runs a zero-equity program for growth-stage startups[52]
- Technopark Zurich provides co-working and event programming, hosting the ZKB Pioneer Award for deep tech
Lausanne’s ecosystem centers on university-embedded programs:
- MassChallenge Switzerland operates a prominent zero-equity accelerator. It hosted 118 startups in its 2024 cohort and distributed CHF 400’000 in cash prizes[53][54]
- EPFL Innovation Park runs specialized accelerators including Tech4Trust (cybersecurity), Tech4Eva (femtech), and Tech4Regen (sustainability)[55]
- Innovaud provides cantonal innovation support, connecting startups with funding and resources[56]
Both cities benefit from national programs like Venture Kick. Venture Kick provides up to CHF 150’000 in pre-seed funding through a three-stage model[57]. Many ETH and EPFL startups progress through Venture Kick regardless of their geographic base.
For founders, accelerator selection should match startup stage and needs. Early-stage companies benefit from university-embedded programs offering lab access and technical mentorship. Growth-stage companies gain more value from corporate-connected accelerators like Kickstart. Kickstart helped create 16 partnership deals for 15 Swiss startups in 2024[58].
For investors, accelerator participation signals founder commitment to structured development. MassChallenge’s 2024 cohort rated the program as the “best ever” at 78%[59]. This suggests strong founder satisfaction and program quality. Investors can use accelerator networks for deal sourcing and preliminary diligence.
Market Access and Geographic Positioning
The choice between Zurich and Lausanne creates different market access dynamics.
Zurich serves as the gateway to the German-speaking DACH market. DACH stands for Germany, Austria, and Switzerland. This market represents Europe’s largest economy. For B2B software and enterprise solutions, this positioning provides direct customer access. Zurich Airport offers better intercontinental connections compared to Geneva. This helps with travel to global tech hubs and investor meetings.
The concentration of financial services headquarters makes Zurich ideal for fintech targeting banking and insurance customers. The regulatory infrastructure around financial services creates natural expertise. Startups navigating compliance requirements benefit from this.
Lausanne provides access to French-speaking Romandie and natural entry to French markets. The proximity to Geneva (62 kilometers) creates opportunities with international organizations.
The life sciences infrastructure around Lausanne, particularly Biopôle, creates cluster effects for medtech and biotech. Specialized suppliers, contract research organizations, and regulatory consultants concentrate in the region. The connection to Basel’s pharma giants remains strong. Superlab Suisse has opened facilities in both Lausanne and Basel in 2024[60].
For founders considering international expansion, both cities provide paths but to different markets. A Zurich-based startup naturally expands into German-speaking Europe. It positions for US market entry through investor networks. A Lausanne-based startup uses French connections and Geneva’s international presence.
For investors evaluating market access, founder location decisions should align with go-to-market strategy. A cybersecurity company serving financial institutions should be in Zurich. Or it should have a clear plan for Zurich customer development. A medical device company should be in or near Lausanne to access regulatory expertise and hospital partnerships.
Basel and Zug: Specialized Hubs Worth Understanding
While Zurich and Lausanne compete as general innovation centers, Basel and Zug operate as specialized ecosystems. They complement rather than compete.
Basel dominates Swiss biotech and pharma. The region hosts 900 life sciences companies[61]. It captured 44% (CHF 328 million) of Swiss biotech venture capital in 2024[62]. BaseLaunch incubator provides up to CHF 500’000 per startup[63]. It maintains partnerships with Roche, Novartis, Johnson & Johnson, CSL, and AbbVie[64][65].
For founders developing therapeutics or requiring pharma partnerships, Basel provides infrastructure and expertise unavailable elsewhere in Switzerland. Recent exits show corporate interest. AstraZeneca acquired SixPeaks Bio in 2024[66]. Roche acquired T3 Pharma for CHF 450 million in 2023[67].
For investors focused on life sciences, Basel deal flow represents high-risk, high-reward opportunities with clear acquisition exit paths.
Zug remains the heart of Crypto Valley. It hosts 719 blockchain companies representing 41% of the broader Crypto Valley total across Switzerland and Liechtenstein[68]. The canton committed CHF 40 million in March 2024 to create a Blockchain Research Institute[69][70].
CV Labs added 38 new startups to its incubator in 2024, marking a 124% increase[71]. Notable companies like 21Shares continue global expansion with cryptocurrency ETFs. The ecosystem has matured beyond speculative DeFi projects. It now focuses on blockchain infrastructure and enterprise applications.
For founders in blockchain and crypto, Zug provides regulatory clarity, tax advantages[72][73], and concentrated domain expertise.
For investors, Zug represents specialized exposure to blockchain infrastructure rather than speculative token projects.
Making the Decision: A Framework for Founders and Investors
The choice between Zurich and Lausanne depends on specific circumstances rather than absolute superiority.
Founders should choose Zurich if:
- Building B2B software or SaaS serving enterprise customers
- Targeting fintech or insurtech markets requiring banking partnerships
- Needing large growth-stage funding rounds (Series B and beyond)
- Prioritizing access to German-speaking markets
- Building AI or robotics with heavy engineering talent requirements
Founders should choose Lausanne if:
- Developing life sciences, medtech, or biotech requiring lab infrastructure
- Building cleantech or sustainability solutions aligned with EPFL research
- Optimizing for lower burn rate while accessing world-class technical talent
- Targeting French-speaking markets or Geneva’s international organizations
- Requiring specialized hardware development capabilities and cleanroom access
Investors should recognize:
- Zurich provides deal flow volume and sector diversification
- Lausanne offers concentrated exposure to deep tech and life sciences
- Basel is essential for therapeutic development and pharma partnerships
- Zug represents specialized blockchain infrastructure opportunities
- Founder location decisions signal strategic thinking and market understanding
The gap between ecosystems narrows for exceptional companies. Neural Concept raised $27 million in Lausanne[74], showing that global capital can flow into strong opportunities regardless of location. Mimic raised $16 million in Zurich from international VCs despite being a hardware robotics company[75]. This category is often associated with Lausanne.
For family offices and institutional investors building Swiss startup portfolios, geographic diversification captures different risk-return profiles. A portfolio of three Zurich fintech companies, two Lausanne medtech ventures, and one Basel biotech startup provides sector exposure. It also hedges against regional economic shifts.
Recent Developments Signal Continued Growth
Both ecosystems showed strong momentum through 2024 and early 2025.
Zurich saw significant capital formation. Redalpine closed a €179 million fund[76]. Founderful raised $85 million[77]. The startup count grew 35.3% according to StartupBlink rankings[78]. Infrastructure developments included the FoodHUB Wädenswil opening in February 2024 to support agro-food innovation[79].
Lausanne achieved notable recognition. Its Greater Lausanne Region ranked as the 11th emerging ecosystem globally in the 2024 Global Startup Ecosystem Report[80][81]. The launch of the Swiss National AI Institute in October 2024 (jointly with ETH Zurich)[82] and the Genolier Innovation Hub opening in September 2024[83] show sustained investment in research infrastructure.
Both cities benefit from Switzerland’s overall innovation leadership. The country maintained its first-place ranking in the Global Innovation Index for the 14th consecutive year. Total Swiss VC investment reached CHF 2.4 billion in 2024[84].
The deep tech sector showed particular strength. Swiss deep tech investments grew 114% in Q1 2024 compared to Q1 2023[86]. Both Zurich and Lausanne contributed to this growth.
For investors, these trends suggest sustained ecosystem health rather than speculative bubble dynamics. The diversification across sectors (fintech in Zurich, life sciences in Lausanne, biotech in Basel, blockchain in Zug) provides resilience against single-sector downturns.
Conclusion: Location as Strategic Choice
The decision between Zurich and Lausanne reflects strategic priorities rather than binary superiority. Zurich offers capital depth, financial services infrastructure, and access to German-speaking markets. Lausanne provides specialized life sciences capabilities, sustainability focus, and cost efficiency.
Founders should evaluate sector fit, target customers, funding requirements, and talent needs before selecting a location. The costs of choosing incorrectly include extended fundraising timelines, difficulty recruiting specialized talent, and weaker corporate partnership opportunities.
Investors should understand that founder location decisions signal strategic sophistication. A fintech in Lausanne or a medtech in Zurich requires explanation. Geographic misalignment may indicate poor market understanding or personal preference overriding business logic.
The integration of Basel’s biotech strength and Zug’s Crypto Valley specialization shows Switzerland’s multi-center model. Rather than competing for dominance, these ecosystems serve complementary functions within a national innovation system ranked first globally.
For international observers, Switzerland’s cantonal structure creates an unusual startup landscape. Multiple specialized hubs thrive rather than a single dominant city extracting all opportunities. This structure appears sustainable given continued growth across all major ecosystems through 2024 and 2025.
The choice between Zurich and Lausanne matters. The framework for making that choice depends on clear assessment of sector dynamics, funding landscapes, talent requirements, and market access priorities. Both cities offer world-class opportunities. The question is which one aligns with specific strategic needs.
About CapiWell
CapiWell is Switzerland’s first multi-asset private capital platform, designed to connect investors with opportunities across real estate, SME lending, and growth-stage startups. For investors seeking access to Swiss ventures past the early risk phase but not yet public, CapiWell’s offers structured exposure to Switzerland’s innovation ecosystem.
References
[1] StartupBlink, Zurich Startup Ecosystem (2025)
[2] Dealroom.co, “Mapping the Zurich Startup Ecosystem: New Open Access Startup Database” (May 2025)
[3] Seedblink, “Switzerland: The Startup Heaven in the Heart of Europe” (March 2024)
[4] StartupBlink, Lausanne Startup Ecosystem
[5] Sifted, “Lausanne Tech Hub”
[6] Startup.ch, Zurich Startup Ecosystem Overview
[7] Wired, “The Hottest Startups in Zurich in 2024”
[8] Venturelab, “Vaud-based Startups Raised Over Half a Billion in 2022”
[9] Startupticker, “Start-up Boom Thriving at ETH Zurich” (January 2025)
[10] Venturelab, “Vaud-based Startups Raised Over Half a Billion in 2022”
[11] Basel Area, “Basel Area Remains the Number One Swiss Biotech Hotspot” (2024)
[12] Startup.ch, Zurich Startup Ecosystem Overview
[13] PME, “La Région Greater Lausanne Classée 10e Parmi les Écosystèmes Internationaux Émergents” (July 2025)
[14] ETH Zurich, “Press Release: ETH Spin-offs Set Annual Record in 2023” (January 2024)
[15] Startupticker, “Start-up Boom Thriving at ETH Zurich” (January 2025)
[16] Startupticker, “Start-up Boom Thriving at ETH Zurich” (January 2025)
[17] Startupticker, “News Archive” (2024)
[18] Startupticker, “News Archive” (2024)
[19] ETH Entrepreneurship, “Discover Entrepreneurship Ecosystem”
[20] ETH Zurich, “ETH Spin-off Report 2024”
[21] EPFL Innovation Park, Official Website
[22] Innovaud, “EPFL Innovation Park”
[23] EPFL, “Innovation and Startup”
[24] ICT Journal, “Les Start-up Suisses Ont Attiré des Centaines de Millions en 2024” (December 2024)
[25] EU-Startups, “The Future of Swiss Tech: 10 Promising Startups You Should Keep an Eye on in 2025” (March 2025)
[26] Crunchbase, “Swiss Startups: Switzerland Tech”
[27] Startup Genome, “Greater Lausanne Region Ecosystem”
[28] Startupticker, “A Deep Dive into Zurich’s Private Equity Landscape” (2024)
[29] EU-Startups, “Zurich-based Venture Capital Firm Redalpine Closes a New Record Fund of Over €179 Million” (August 2024)
[30] Growth Mentor, “Zurich Venture Capital”
[31] Zurich Insurance Group, “Innovation and Technology at Zurich”
[32] ETH Zurich, “Strengthening Switzerland’s Start-up Ecosystem” (March 2024)
[33] BCV, “Initiative Capital Romandie: Un Nouveau Fonds de Capital-Risque Pour les Jeunes Entreprises Vaudoises et Romandes Est Né” (2006)
[34] Failory, “Venture Capital Firms in Lausanne”
[35] EPFL, “Startup Champions Seed Night Community Events”
[36] Startupticker, “News Archive” (2024)
[37] Startupticker, “News Archive” (2024)
[38] Startup Genome, “Greater Lausanne Region Ecosystem”
[39] Glassdoor, “Zurich Software Engineer Salary” (November 2025)
[40] Glassdoor, “Lausanne Software Engineer Salary” (November 2025)
[41] SalaryExpert, “Software Engineer Salary in Zurich, Switzerland”
[42] SalaryExpert, “Software Applications Engineer Salary in Lausanne, Switzerland”
[43] Startupticker, “SICTIC Investor Day at Google Zurich”
[44] Innovation Zurich, “Hubs”
[45] Startupticker, “Nestlé R&D Accelerator Lausanne”
[46] BaseLaunch, “About Us”
[47] Basel Area, “Media Release: BaseLaunch Announces a New Partnership with AbbVie” (May 2024)
[48] Startupticker, “News Archive” (2024)
[49] Basel Area, “Fünf Startups aus der Basel Area unter den Top 100 der Swiss Startup Awards”
[50] Bluelion, Official Website
[51] Growth Mentor, “Zurich Startup Accelerators”
[52] Growth Mentor, “Zurich Startup Accelerators”
[53] Startupticker, “News Archive” (2024-2025)
[54] MassChallenge, “Programs Switzerland”
[55] EPFL Innovation Park, “Startups Acceleration”
[56] Startup Genome, “Greater Lausanne Region Ecosystem”
[57] Venture Kick, Official Website
[58] Growth Mentor, “Zurich Startup Accelerators”
[59] MassChallenge, “Programs Switzerland”
[60] DDW Online, “Drug Discovery Hotspots: What is the Secret to Switzerland’s Success Part 1” (July 2024)
[61] BioValley, Official Website
[62] Basel Area, “Basel Area Remains the Number One Swiss Biotech Hotspot” (2024)
[63] BaseLaunch, Official Website
[64] BaseLaunch, “About Us”
[65] Basel Area, “Media Release: BaseLaunch Announces a New Partnership with AbbVie” (May 2024)
[66] Startupticker, “News Archive” (2024)
[67] Basel Area, “Fünf Startups aus der Basel Area unter den Top 100 der Swiss Startup Awards”
[68] Editorial GE, “Zug: Crypto Valley, Top Blockchain Hub”
[69] Netzwoche, “Das Crypto Valley Erhält ein Blockchain-Institut” (March 2024)
[70] Canton of Zug, “Zug als Globales Zentrum für Blockchaintechnologie” (2024)
[71] Editorial GE, “Zug: Crypto Valley, Top Blockchain Hub”
[72] Equal Ocean, “Analysis” (January 2020)
[73] Awisee, “Starting a Crypto Company in Zug”
[74] ICT Journal, “Les Start-up Suisses Ont Attiré des Centaines de Millions en 2024” (December 2024)
[75] Startupticker, “News Archive” (2024)
[76] EU-Startups, “Zurich-based Venture Capital Firm Redalpine Closes a New Record Fund of Over €179 Million” (August 2024)
[77] Growth Mentor, “Zurich Venture Capital”
[78] StartupBlink, Zurich Startup Ecosystem (2025)
[79] Innovation Zurich, “Hubs”
[80] PME, “La Région Greater Lausanne Classée 10e Parmi les Écosystèmes Internationaux Émergents” (July 2025)
[81] Startup Genome, “Greater Lausanne Region Ecosystem”
[82] Startup Genome, “Greater Lausanne Region Ecosystem”
[83] Startup Genome, “Greater Lausanne Region Ecosystem”
[84] Greater Zurich Area, “Startup” (2024)
[85] Wired, “The Hottest Startups in Zurich in 2024”
[86] Startupticker, “Deeptech is Reviving the Swiss Startup Ecosystem”
